Ramelteon
Brand names: Ramelteon, Rozerem
At a glance
- Medicare prescriptions, 2024
- 109,387
- Medicare drug cost
- $11.1M
- Average cost per prescription
- $101
- Clinicians who prescribed it
- 5,176
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
ROZEREM ® is indicated for the treatment of insomnia characterized by difficulty with sleep onset. The clinical trials performed in support of efficacy were up to six months in duration. The final formal assessments of sleep latency were performed after two days of treatment during the crossover study (elderly only), at five weeks in the six week studies (adults and elderly), and at the end of the six month study (adults and elderly).
From the FDA-approved prescribing information (label dated April 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Psychiatry 23.7%
- Family Medicine 16.2%
- Internal Medicine 16.2%
- Psychiatric Nurse Practitioners 14.8%
- Nurse Practitioners 12.7%
- Physician Assistants 3.8%
- Geriatric Medicine 2.9%
- Neurology 2.0%
- Pulmonology 1.2%
- General Practice 1.2%
- Child & Adolescent Psychiatry 0.9%
- Sleep Medicine 0.9%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 79% from 2019 to 2024.
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 5 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Advanced Rx of Tennessee, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 8 mg | yellow round tablet, 7 mm | RM |
Remedyrepack Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 8 mg | yellow round tablet, 7 mm | AC 414 |
Sportpharm LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 8 mg | yellow round tablet, 7 mm | RM |
Takeda Pharmaceuticals America, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 8 mg | orange round tablet, 7 mm | TAK RAM 8 |
Xiromed, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 8 mg | orange round tablet, 7 mm | C |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.